CG Oncology Inc. (CGON)
$78.23-1.98%Close
BUYBULL · day 11
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $6.9B
- Avg volume
- 986.6K
- Beta
- 0.23
- P/E (TTM)
- -28.97
- Short % float
- 17.99%
- Days to cover
- 13.5
- SI change
- -2.2%
- 1W
- +1.45%
- 1M
- +12.85%
- 3M
- +21.76%
- YTD
- +87.20%
- vs SPY 1W
- +2.64%
- vs SPY 1M
- +9.53%
- vs SPY 3M
- +19.37%
- vs SPY YTD
- +75.44%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- DNLIBUYDenali Therapeutics Inc.RECOVERYQ 10$24.20-2.89%
- ESTASELLEstablishment Labs Holdings Inc.CRISISQ 17$72.06-0.84%
- CNTBBUYConnect Biopharma Holdings LimitedRECOVERYQ -12$2.30-2.54%
- KYMRBUYKymera Therapeutics, Inc.BULLQ 27$121.05+1.04%
- ROIVBUYRoivant Sciences Ltd.BULLQ 31$36.36+0.17%
- FHTXBUYFoghorn Therapeutics Inc.RECOVERYQ 4$6.87-2.83%
- COYABUYCoya Therapeutics, Inc.RECOVERYQ 9$4.96+1.85%
- ABCLBUYAbCellera Biologics Inc.RECOVERYQ -7$10.61-6.27%
- RCUSBUYArcus Biosciences, Inc.RECOVERYQ 19$30.12-0.73%
- CTSOSELLCytosorbents CorporationCRISISQ 2$0.37+0.00%
- LYRASELLLyra Therapeutics, Inc.CRISISQ -25$0.01
- ANGOBUYAngioDynamics, Inc.BULLQ 5$15.77+0.13%
Industry peers
FMP comparable companies · ranked by market cap
- APGEBUYApogee Therapeutics, Inc.$8.3BBULLQ 60$134.79+0.03%
- CNTABUYCentessa Pharmaceuticals plc$6.3BBULLQ 17$40.50+0.00%
- TVTXBUYTravere Therapeutics, Inc.$6.1BBULLQ 34$65.22-0.75%
- XENESELLXenon Pharmaceuticals Inc.$5.9BBEARQ 26$60.56-0.35%
- CELCSELLCelcuity Inc.$4.4BRECOVERYQ 29$90.79-2.93%
- LEGNBUYLegend Biotech Corporation$3.9BRECOVERYQ 4$20.94-4.03%
- TARSBUYTarsus Pharmaceuticals, Inc.$3.1BRECOVERYQ 24$72.81+0.15%
- IRONBUYDisc Medicine, Inc.$3.1BRECOVERYQ 4$80.94+1.42%
- RARESELLUltragenyx Pharmaceutical Inc.$2.5BRECOVERYQ -1$25.72-0.43%
- AAPGSELLAscentage Pharma Group International$1.6BCRISISQ 8$16.71-1.71%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 4
- VALUE
- 6
- GROWTH
- 4
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-15.1%
REV YoY-
ROE-25.2%
EPS YoY-
ROA-20.7%
GROSS-83
OP-4056
NET-3603
[VALUATION]
P/E TTM-28.97
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B6.70
P/FCF-
EV/EBITDA-31.00
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.86
ALTMAN Z-
CURR RATIO22.22
ND/EBITDA-
BETA0.23
